A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism
Authors:
- 31 March 2007
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (8) , 1219-1223
Abstract
Bartter syndrome (BS) is a genetic disorder with hypokalemic metabolic alkalosis and is classified into five types. One of these, type II BS (OMIM 241200), is classified as neonatal Bartter syndrome, which is caused by mutations in the KCNJ1 gene. Transient hyperkalemia and hyponatremia are usually noted in the early postnatal period, but as type II BS is a relatively rare disease, its exact clinical course and genetic background have not yet been thoroughly characterized. This report concerns a male type II BS patient with a novel mutation in the KCNJ1 gene. The unique clinical findings of this case are that hyperkalemia (8.9 mEq/l), hyponatremia, and metabolic acidosis detected in the early postnatal period led to a diagnosis of pseudohypoaldosteronism (PHA). As an adolescent, however, the patient currently shows normal potassium levels and normal renal function, although with hypercalciuria and nephrocalcinosis, without having received any treatment. In such cases, KCNJ1 mutations should be suspected. In our case, genetic analysis of the KCNJ1 gene identified a novel homozygous 1-bp deletion mutation (c.607 del. C in exon 5).Keywords
This publication has 20 references indexed in Scilit:
- Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K dietKidney International, 2006
- Potassium handling in health and disease: lessons from inherited tubulopathies.2004
- Ontogeny of flow-stimulated potassium secretion in rabbit cortical collecting duct: functional and molecular aspectsAmerican Journal of Physiology-Renal Physiology, 2003
- Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndromeThe Journal of Pediatrics, 2003
- Association between activating mutations of calcium-sensing receptor and Bartter's syndromeThe Lancet, 2002
- Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathiesThe American Journal of Medicine, 2002
- Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndromeKidney International, 2001
- Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type IIINature Genetics, 1997
- Genetic heterogeneity of Barter's syndrome revealed by mutations in the K+ channel, ROMKNature Genetics, 1996
- Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2Nature Genetics, 1996